CN100998560A — 多烯紫杉醇冻干乳剂及其制备方法
Assigned to Shenyang Pharmaceutical University · Expires 2007-07-18 · 19y expired
What this patent protects
本发明属于医药技术领域,公开了多烯紫杉醇冻干乳剂及其制备方法。它以多烯紫杉醇为主要成分,并含有注射用油、乳化剂、稳定剂、pH调节剂、等渗调节剂、冻干保护剂、其余为注射用水,多烯紫杉醇的重量体积浓度范围为0.5-5.0mg/ml。制备的多烯紫杉醇注射用冻干乳剂可以按需要量加水,水合振荡后复原成乳剂,经静脉注射给药。本发明具有制备工艺简便、质量可控、载药量大、稳定性好等优点。且能显著提高多烯紫杉醇的稳定性,并具有一定的靶向性,可以更好地发挥药效,降低毒性。
USPTO Abstract
本发明属于医药技术领域,公开了多烯紫杉醇冻干乳剂及其制备方法。它以多烯紫杉醇为主要成分,并含有注射用油、乳化剂、稳定剂、pH调节剂、等渗调节剂、冻干保护剂、其余为注射用水,多烯紫杉醇的重量体积浓度范围为0.5-5.0mg/ml。制备的多烯紫杉醇注射用冻干乳剂可以按需要量加水,水合振荡后复原成乳剂,经静脉注射给药。本发明具有制备工艺简便、质量可控、载药量大、稳定性好等优点。且能显著提高多烯紫杉醇的稳定性,并具有一定的靶向性,可以更好地发挥药效,降低毒性。
Drugs covered by this patent
- Taxotere (Docetaxel) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.